+49 711 500 989 80
deen

First patient-derived cells to study leptomeningeal disease



First patient-derived cells to study leptomeningeal disease

A team of researchers has been able to add an important resource to study leptomeningeal disease by successfully growing and culturing circulating tumor cells derived from the cerebrospinal fluid of patients with melanoma leptomeningeal disease.

Materials provided by H. Lee Moffitt Cancer Center & Research Institute. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

27th May 2022

High cost of cancer care in the U.S. doesn't reduce mortality rates

Read more
27th May 2022

T cell warriors need their R & R

Read more
27th May 2022

New cancer subtype may illuminate treatment strategy

Read more